PURE

PURE BIOSCIENCE INC COM STK NEW (DE)
PURE

Overview Fund Activity
Delisted

PURE was delisted on the 16th of May, 2013.

Back to rankings
Materials Specialty Chemicals

Financial journalist opinion

Neutral
Business Wire
2 months ago
PURE Bioscience Partners with Bonsai for Direct-to-Customer Sales
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial and Bonsai (“Bonsai”), has entered into a multi-year distribution agreement for the purchase and sale of SDC products under special terms and conditions. This agreement authorizes Bonsai as an official distributor of PURE's EPA-registered disinfectants, expanding market access to PURE's revolutionary Silver Dihydr.
PURE Bioscience Partners with Bonsai for Direct-to-Customer Sales
Neutral
Business Wire
2 months ago
PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2025. Summary of Results of Operations – Fiscal Third Quarter Net product sales were $489,000 and $440,000 for the fiscal third quarter ended April 30, 2025 and 2024, respectively. The increase of $49,000 was attributable to increased s.
PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results
Neutral
Business Wire
3 months ago
PURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is proud to announce an innovative application method for membrane treatment in the dairy and beverage industry using our flagship product, PURE® Hard Surface. This groundbreaking solution addresses common membrane fouling and sanitization challenges, delivering outstanding results that enable operators to restor.
PURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry
Neutral
Business Wire
5 months ago
PURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2025. Summary of Results – Fiscal Second Quarter Operations Net product sales were $391,000 and $325,000 for the fiscal second quarter ended January 31, 2025 and 2024, respectively. The increase of $66,000 was attributable to increas.
PURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results
Neutral
Business Wire
7 months ago
PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Hydrite Chemical Company (“Hydrite”) have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is excited to announce the signing of a strategic distribution agreement with Hydrite, a top-tier provider of complete solutions for.
PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
Neutral
Business Wire
8 months ago
PURE Bioscience Unveils New Brand Identity
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and branded by Greenville (“bbG”), is excited to announce the official start of an extensive rebranding campaign to renew its corporate vision. This rebranding initiative aims to strengthen the Company's identity and culture in the market and to better reflect its commitment to cutting-edge scientific advancement.
PURE Bioscience Unveils New Brand Identity
Neutral
Business Wire
8 months ago
PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2024. Summary of Results – Fiscal First Quarter Operations Net product sales were $555,000 and $718,000 for the fiscal first quarters ended October 31, 2024 and 2023, respectively. The decrease of $163,000 was attributable to budgetar.
PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results
Neutral
Business Wire
9 months ago
PURE Bioscience Announces Distribution Agreement with AFCO, a Zep Company
EL CAJON, Calif.--(BUSINESS WIRE)-- #AFCO--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and AFCO, a Zep Company (“AFCO”), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is excited to announce the signing of a strategic distribution agreement with AFCO, a leading provider of cleaning and sanitation solutions.
PURE Bioscience Announces Distribution Agreement with AFCO, a Zep Company
Neutral
Business Wire
10 months ago
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
EL CAJON, Calif.--(BUSINESS WIRE)-- #AALAS--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Quip Laboratories, Inc. (“Quip Labs”), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is pleased to announce the signing of a strategic distribution agreement with Quip Labs, a distinguished leader in solutions for th.
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
Neutral
Business Wire
10 months ago
PURE Bioscience Reports Fiscal 2024 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2024. Summary of Results – Year-End Operations Net product sales were $1,955,000 and $1,871,000 for the fiscal year ended July 31, 2024 and 2023, respectively. The increase of $84,000 was attributable to increased sales across our distribution ne.
PURE Bioscience Reports Fiscal 2024 Financial Results
See News Rankings
Charts implemented using Lightweight Charts™